Defining the road map to a UK national lung cancer screening programme

O'Dowd, Emma L, Lee, Richard W, Akram, Ahsan R, Bartlett, Emily C, Bradley, Stephen H, Brain, Kate ORCID: https://orcid.org/0000-0001-9296-9748, Callister, Matthew E J, Chen, Yan, Devaraj, Anand, Eccles, Sinan R, Field, John K, Fox, Jesme, Grundy, Seamus, Janes, Sam M, Ledson, Martin, MacKean, Melanie, Mackie, Anne, McManus, kieran G, Murray, Rachael L, Nair, Arjun, Quaife, Samantha L, Rintoul, Robert, Stevenson, Anne, Summers, Yvonne, Wilkinson, Louise S, Booton, Richard, Baldwin, David R and Crosbie, Philip 2023. Defining the road map to a UK national lung cancer screening programme. The Lancet Oncology 24 (5) , E207-E218. 10.1016/S1470-2045(23)00104-3

Preview

PDF - Accepted Post-Print Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (457kB) | Preview

Abstract

Lung cancer screening with low-dose CT was recommended by the UK National Screening Committee (UKNSC) in September, 2022, on the basis of data from trials showing a reduction in lung cancer mortality. These trials provide sufficient evidence to show clinical efficacy, but further work is needed to prove deliverability in preparation for a national roll-out of the first major targeted screening programme. The UK has been world leading in addressing logistical issues with lung cancer screening through clinical trials, implementation pilots, and the National Health Service (NHS) England Targeted Lung Health Check Programme. In this Policy Review, we describe the consensus reached by a multiprofessional group of experts in lung cancer screening on the key requirements and priorities for effective implementation of a programme. We summarise the output from a round-table meeting of clinicians, behavioural scientists, stakeholder organisations, and representatives from NHS England, the UKNSC, and the four UK nations. This Policy Review will be an important tool in the ongoing expansion and evolution of an already successful programme, and provides a summary of UK expert opinion for consideration by those organising and delivering lung cancer screenings in other countries.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Elsevier
ISSN:	1470-2045
Funders:	The Roy Castle Lung Cancer Foundation
Date of First Compliant Deposit:	17 May 2023
Date of Acceptance:	9 April 2023
Last Modified:	13 Nov 2024 12:15
URI:	https://orca.cardiff.ac.uk/id/eprint/159564

Actions (repository staff only)

Edit Item